Signature
/s/ Ronald J. Artinian
Issuer symbol
FREVS
Transactions as of
27 Jan 2023
Net transactions value
$0
Form type
4
Filing time
31 Jan 2023, 14:52:31 UTC
Previous filing
01 Nov 2022
Next filing
13 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FREVS Common Stock, par value $0.01 per share Other +72,775 +18% 484,813 27 Jan 2023 Direct F1, F2
holding FREVS Common Stock, par value $0.01 per share 4,350 27 Jan 2023 By Son F1, F3
holding FREVS Common Stock, par value $0.01 per share 52,504 27 Jan 2023 By IRAs F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Prior to the reincorporation of First Real Estate Investment Trust of New Jersey, Inc. ("FREIT") from a New Jersey real estate investment trust to a Maryland corporation on July 1, 2021, FREIT's equity securities were beneficial interests in FREIT that were designated as "shares" without par value. In connection with the reincorporation of FREIT as a Maryland corporation, FREIT's shares of beneficial interest were converted to shares of common stock, par value $0.01 per share, on a 1-for-1 basis.
F2 As disclosed in FREIT's filings with the Securities and Exchange Commission, on November 4, 2021, FREIT's Board of Directors approved the termination of FREIT's Amended and Restated Deferred Fee Plan. In connection with the termination of the Amended and Restated Deferred Fee Plan, all Share Units credited to each participant's account for the deferral of fees under the Amended and Restated Deferred Fee Plan were distributed to the participants as shares of FREIT's common stock, par value $0.01 per share. The filing of FREIT's Annual Report on Form 10-K for the fiscal year ended October 31, 2022 on January 27, 2023 served as notice of the execution of the distribution of such shares under the Amended and Restated Deferred Fee Plan to the reporting person.
F3 Shares held by Mr. Artinian's son, Ronald K. Artinian.